Cardiovascular Research at the DCRI
The world looks to the DCRI as the leader in cardiovascular clinical research, implementation science, and education. To celebrate Heart Month, we’re revisiting vital findings, groundbreaking studies, and how the DCRI is innovating the future of clinical trials to improve patient care.
- Blood pressure intervention programs vary in effectiveness, but show promise.
- Women with CAD symptoms receive different treatment, but have similar outcomes.
- Coronary heart disease drops 20 percent since the 1980s.
- More heart patients are receiving subcutaneous defibrillators.
- DCRI awarded first PCORnet demonstration study to determine best aspirin dose to protect patients with heart disease.
- DCRI partners with AHA to launch precision medicine data marketplace.
The DCRI’s Sana Al-Khatib, MD, addresses the challenges of reducing healthcare disparities among heart failure patients using device therapy.
Heart failure specialist G. Michael Felker, MD, MHS, discusses why he chose to work at Duke and the DCRI.